How should chimerism be decoded?1

To date, the significance of chimerism has not been fully understood. In particular, microchimerism can be associated with allograft acceptance or rejection. Several factors may influence the immunologic consequences of chimerism. In this review, the major factors influencing these consequences are briefly described. Subsequently, the different methods available for detecting and tracking donor-derived cells are listed. These techniques have been mainly developed concomitantly with nonmyeloablative hematopoietic allografts to monitor immunosuppression. Finally, the authors suggest how these methods may help to improve the understanding of microchimerism in solid organ transplantation.

[1]  A. Hagenbeek,et al.  Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat. , 2004, Experimental hematology.

[2]  M. Bernard,et al.  Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. , 2002, Blood.

[3]  I. Lossos,et al.  Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. , 2002, Blood.

[4]  A. Barrett,et al.  Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. , 2001, Blood.

[5]  C. Contag,et al.  Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 , 2001, The Journal of Immunology.

[6]  M. Sykes,et al.  Mixed chimerism and transplant tolerance. , 2001, Immunity.

[7]  Craig W. Reynolds,et al.  Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. , 2001, Blood.

[8]  A. Zander,et al.  CD34 splice variant: an attractive marker for selection of gene-modified cells. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  T. Barbui,et al.  Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies. , 2000, Human gene therapy.

[10]  N. Young,et al.  Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. , 1999, Blood.

[11]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[12]  M. Florek,et al.  Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection , 1999, Bone Marrow Transplantation.

[13]  T. Starzl,et al.  Antigen localization and migration in immunity and tolerance. , 1998, The New England journal of medicine.

[14]  K. Okasha,et al.  Analysis of the relationship between chimerism and the allgeneic humoral response. , 1998, Transplantation.

[15]  G. Szot,et al.  Separate regulation of peripheral hematopoietic and thymic engraftment. , 1998, Experimental hematology.

[16]  S. Jimenez,et al.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. , 1998, The New England journal of medicine.

[17]  H. Schlitt,et al.  Donor-type microchimerism associated with graft rejection eight years after liver transplantation. , 1994, The New England journal of medicine.

[18]  C. Ricordi,et al.  Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. , 1993, Trends in pharmacological sciences.

[19]  B. Budowle,et al.  Population genetics and forensic efficiency data of 4 AMPFLP's , 1992, International Journal of Legal Medicine.

[20]  S. Orkin,et al.  Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms. , 1985, The Journal of clinical investigation.

[21]  P. Matzinger,et al.  Immunity or tolerance: Opposite outcomes of microchimerism from skin grafts , 2001, Nature Medicine.

[22]  S. Riddell,et al.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells , 1999, Nature Medicine.

[23]  C. Bordignon,et al.  Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. , 1994, Blood.